Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole Augmentation Pilot in Depression (RAPID)
NCT01703039Phase 2Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2013
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of riluzole in major depressive disorder (MDD), sponsored by Brigham and Women's Hospital. Started Jan 2013; status: terminated.
02
Drugs
riluzole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01703039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703039.